BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220726
DTEND;VALUE=DATE:20220730
DTSTAMP:20260516T024009
CREATED:20220425T085640Z
LAST-MODIFIED:20220425T085640Z
UID:33898-1658793600-1659139199@www.pharmajournalist.com
SUMMARY:Cytokine-Based Drug Development Summit
DESCRIPTION:The 3rd Cytokine-Based Drug Development Summit has been developed following extensive research to address YOUR biggest challenges in the cytokine field. \nWith 30+ expert speakers\, including the hottest academic researchers and leading figures from the industry\, this 4-day program is your opportunity to gain insight into the latest clinical advancement and have thought provoking discussions around how to overcome the fields greatest drug development challenges. \nWhat can you expect to see? \n\nFurther your understanding of the underlying mechanisms of action\, and T-cell exclusion from the tumor in order to turn cold tumors ‘hot’ with Ask-Gene Pharma\nOptimize cytokine engineering to ensure stability and improve the favorable risk benefit profile with Proviva Therapeutics\nLeverage insights from industry’s leading lights to overcome toxicity challenges by ensuring tumor targeting is selective and therefore enhances the anti-tumor response with Equilium\, Cytonus Therapeutics & Cytimmune\nTake a deep dive into preclinical cancer models covering both in vitro and in-vivo studies and how these are unveiling the most favoured pharmaceuticals properties of therapeutic cytokines with Astra Zeneca & Xilio Therapeutics\nUncover the latest data coming out of the clinic of cytokines in combination with checkpoint inhibitors and monoclonal antibodies with Alkermes & NeoImmune Tech\n\nGet your copy of the brand-new agenda for the full list of speakers and sessions.
URL:https://www.pharmajournalist.com/event/cytokine-based-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR